Use of imaging in the management of malignant pleural mesothelioma

Clinical Radiology

Volumn 60, Issue 12, 2005, Pages 1237-1247

  Benamore, R E ^a   O'Doherty, M J ^b   Entwisle, James J ^a,c  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

Biopsy; Computed tomography; CT; Mesothelioma; Pleura

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

CANCER GROWTH; CANCER MORTALITY; CANCER STAGING; CLINICAL FEATURE; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; IMMUNOCYTOCHEMISTRY; LUNG CANCER; LUNG RESECTION; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS BIOPSY; PLEURA MESOTHELIOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RELIABILITY; REVIEW; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY;

BIOPSY, NEEDLE; HUMANS; MAGNETIC RESONANCE IMAGING; MESOTHELIOMA; NEOPLASM STAGING; PLEURA; PLEURAL EFFUSION, MALIGNANT; PLEURAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 28244496153     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crad.2005.05.015     Document Type: Review

References (58)

1. National Statistics Mesothelioma mortality in Great Britain: Estimating the future burden 2003 Health and Safety Executive London
2. From cancer research UK statistics, mortality; 2002 http://www.cancerresearchuk.org/aboutcancer/statistics/ mortality?version=1, accessed May 2005.
3. J. Peto A. Decarli C. la Vecchia et al. The European mesothelioma epidemic Br J Cancer 79 1999 666-672
4. J. Peto H. Seidman I.J. Selikoff Mesothelioma mortality in asbestos workers: Implications for models of carcinogenesis and risk assessment Br J Cancer 45 1982 124-135
5. D.H. Yates B. Corrin P.N. Stidolph et al. Malignant mesothelioma in south east England: Clinicopathological experience in 272 cases Thorax 52 1997 507-512
6. A.R. Gibbs Role of asbestos and other fibres in the development of diffuse malignant mesothelioma Thorax 45 1990 649-654
7. Williams PL, editor. Gray's anatomy. 38th ed. London: Churchill Livingstone; 1995; p. 1625-6, 1662-4, 1917-8.
8. A. Sharma P. Fidias L.A. Hayman et al. Patterns of lymphadenopathy in thoracic malignancies RadioGraphics 24 2004 419-434
9. G. Hillerdal Malignant mesothelioma 1982: Review of 4710 published cases Br J Dis Chest 77 1983 321-343
10. British Thoracic Society Standards of Care Committee Statement on malignant mesothelioma in the United Kingdom Thorax 56 2001 250-265
11. F. Herth Diagnosis and staging of mesothelioma transthoracic ultrasound Lung Cancer 45 2000 S63-S67
12. A.L. Evans F.V. Gleeson Radiology in pleural disease: State of the art Respirology 9 2004 300-312
13. A.N. Leung N.L. Muller R.R. Miller CT in differential diagnosis of diffuse pleural disease AJR Am J Roentgenol 154 1990 487-492
14. Z.C. Traill R.J. Davies F.V. Gleeson Thoracic computed tomography in patients with suspected malignant pleural effusions Clin Radiol 56 2001 193-196
15. M. Metintas I. Ucgun O. Elbek et al. Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases Eur J Radiol 41 2002 1-9
16. A. Senyigit H. Bayram C. Babayigit et al. Malignant pleural mesothelioma caused by environmental exposure to asbestos in the southeast of Turkey: CT findings in 117 patients Respiration 67 2000 615-622
17. A.A. Sahin L. Coplu Z.T. Selcuk et al. Malignant pleural mesothelioma caused by environmental exposure to asbestos and erionite in rural Turkey: CT findings in 84 patients AJR Am J Roentgenol 161 1993 533-537
18. C.S. Ng R.F. Munden H.I. Libshitz Malignant pleural mesothelioma: The spectrum of manifestations on CT in 70 cases Clin Radiol 54 1999 415-421
19. A. Kawashima H.I. Libshitz Malignant pleural mesothelioma: CT manifestations in 50 cases AJR Am J Roentgenol 155 1990 965-969
20. C. Boutin F. Rey J.-R. Viallat Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma Chest 108 1995 754-758
21. E.F. Patz K. Shaffer D.R. Piwnica-Worms et al. Malignant pleural mesothelioma: Value of CT and MR imaging in predicting resectability AJR Am J Roentgenol 159 1992 961-966
22. E.M. Marom J.J. Erasmus H.I. Pass et al. The role of imaging in malignant pleural mesothelioma Semin Oncol 29 2002 26-35
23. G. Hillerdal Staging and evaluating responses in malignant pleural mesothelioma Lung Cancer 43 2004 75-76
24. A.A. Renshaw B.R. Dean K.H. Antman et al. The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma Chest 111 1997 106-109
25. C. Boutin F. Rey Thoracoscopy in pleural malignant mesothelioma: A prospective study of 188 consecutive patients. Part 1. Diagnosis Cancer 72 1993 389-393
26. N.A. Maskell F.V. Gleeson R.J.O. Davies Standard pleural biopsy versus CT-guided cutting needle biopsy for diagnosis of malignant disease in pleural effusions: A randomised controlled trial Lancet 361 2003 1326-1330
27. R.F. Adams W. Gray R.J.O. Davies et al. Percutaneous image-guided cutting needle biopsy of the pleura in the diagnosis of malignant mesothelioma Chest 120 2001 1798-1802
28. R.F. Adams F.V. Gleeson Percutaneous image-guided cutting needle biopsy of the pleura in the presence of a suspected malignant pleural effusion Radiology 219 2001 510-514
29. A. Heilo A.E. Stenwig O.P. Solheim Malignant pleural mesothelioma: US-guided histologic core-needle biopsy Radiology 211 1999 657-659
30. M. Metintas N. Ozdemir S. Isiksoy et al. CT-guided pleural needle biopsy in the diagnosis of malignant mesothelioma J Comput Assist Tomogr 19 1995 370-374
31. D.C. Ng S.F. Hain M.J. O'Doherty et al. Prognostic value of FDG PET imaging in malignant pleural mesothelioma J Nucl Med 41 2000 1443-1444
32. B. Duysinx D. Nguyen R. Louis et al. Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging Chest 125 2004 489-493
33. H. Kramer R.M. Pieterman D.-J. Slebos et al. PET for the evaluation of pleural thickening observed on CT J Nucl Med 45 2004 995-998
34. F. Benard D. Sterman R.J. Smith et al. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography Chest 114 1998 713-722
35. R.M. Flores T. Akhurst M. Gonen et al. Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma J Thorac Cardiovasc Surg 126 2003 11-16
36. V.H. Gerbaudo S. Britz-Cunningham D.J. Sugarbaker et al. Metabolic significance of the pattern, intensity and kinetics of 18F-FDG uptake in malignant pleural mesothelioma Thorax 58 2003 1077-1082
37. F. Benard D. Sterman R.J. Smith et al. Prognostic value of FDG PET imaging in malignant pleural mesothelioma J Nucl Med 40 1999 1241-1245
38. B.H. Kwek S.L. Aquino A.J. Fischman Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis Chest 125 2004 2356-2360
39. V.H. Gerbaudo D.J. Sugarbaker S. Britz-Cunningham et al. Assessment of malignant pleural mesothelioma with 18F-FDG dual-head gamma-camera coincidence imaging: Comparison with histopathology J Nucl Med 43 2002 1144-1149
40. A. Knuuttila L. Kivisaari A. Kivisaari et al. Evaluation of pleural disease using MR and CT with special reference to malignant pleural mesothelioma Acta Radiol 42 2001 502-507
41. J. Hierholzer L. Luo R.C. Bittner et al. MRI and CT in the differential diagnosis of pleural disease Chest 118 2000 604-609
42. D. Stewart D. Waller J. Edwards et al. Is there a role for pre-operative contrast-enhanced magnetic resonance imaging for radical surgery in malignant pleural mesothelioma? Eur J Cardiothorac Surg 24 2003 1019-1024
43. V.W. Rusch A proposed new international TNM staging system for malignant pleural mesothelioma: From the International Mesothelioma Interest Group Chest 108 1995 1122-1128
44. V.W. Rusch J.D. Godwin W.P. Shuman The role of computed tomography scanning in the initial assessment and follow-up of malignant pleural mesothelioma J Thorac Cardiovasc Surg 96 1988 171-177
45. R.T. Heelan V.W. Rusch C.B. Begg et al. Staging of malignant pleural mesothelioma: Comparison of CT and MR imaging AJR Am J Roentgenol 172 1999 1039-1046
46. J.H. Schouwink L.S. Kool E.J. Rutgers et al. The value of chest computer tomography and cervical mediastinoscopy in the preoperative assessment of patients with malignant pleural mesothelioma Ann Thorac Surg 75 2003 1715-1719
47. D.J. Sugarbaker R.M. Flores M.T. Kaklitsch et al. Resection margins, extrapleural nodal status and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients J Thorac Cardiovasc Surg 117 1999 54-65
48. J. Pilling D. Stewart A. Martin-Ucar et al. The case for routine mediastinoscopy prior to radical resection of malignant pleural mesothelioma Chest 124 2003 S75
49. T. Treasure D. Waller S. Swift et al. Radical surgery for mesothelioma BMJ 328 2004 237-238
50. L.R. Goodman Imaging FTER thoracotomy In: L.R. Goodman C.E. Putman editors Critical care imaging 1992 Saunders Philadelphia, PA p. 213-232
51. E.G. Butchart T. Ashcroft W.C. Barnsley et al. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience in 29 patients Thorax 31 1976 15-24
52. WHO: Handbook for reporting results of cancer treatment. Geneva, Switzerland: World Health Organization; 1979 [Offset publication no. 48].
53. P. Therasse S.G. Arbuck E.A. Eisenhauer et al. New guidelines to evaluate the response to treatment in solid tumours J Natl Cancer Inst 92 2000 205-216
54. F. Monetti S. Casanova A. Grasso et al. Inadequacy of the new response evaluation criteria in solid tumours (RECIST) in patients with malignant pleural mesothelioma: Report of four cases Lung Cancer 43 2004 71-74
55. R.J. Van Klaveren J.G.J.V. Aerts H. De Bruin et al. Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma Lung Cancer 43 2004 63-69
56. M.J. Byrne A.K. Nowak Modified RECIST criteria for assessment of response in malignant pleural mesothelioma Ann Oncol 15 2004 257-260
57. S.G. Armato III G.R. Oxnard H. MacMahon et al. Measurement of mesothelioma on thoracic CT scans: A comparison of manual and computer-assisted techniques Med Phys 31 2004 1105-1115
58. A. Carretta C. Landoni G. Melloni et al. 18-FDG positron emission tomography in the evaluation of malignant pleural diseases-a pilot study Eur J Cardiothorac Surg 17 2002 377-383